Status:

NOT_YET_RECRUITING

A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

Lead Sponsor:

Daiichi Sankyo

Conditions:

Primary Hypercholesterolaemia

Mixed Dyslipidemia

Eligibility:

All Genders

18+ years

Brief Summary

There is limited efficacy and safety data of bempedoic acid or its fixed dose combination (FDC) with ezetimibe in Asian and Latin American patients. This non-interventional study (NIS) will be conduct...

Detailed Description

The primary objective of this study is to describe patient characteristics and evaluate adverse drug reactions (ADRs) that occurred since initiation of bempedoic acid/FDC with ezetimibe and adverse ev...

Eligibility Criteria

Inclusion

  • Patients can be enrolled, when they fulfil the following inclusion criteria:
  • Written informed consent to participate.
  • At least 18 years of age.
  • Patients suffering from documented primary hypercholesterolemia or mixed dyslipidaemia treated or intended to be treated with bempedoic acid/ FDC with ezetimibe at the discretion of the physician are appropriate for participation in the observation.
  • For patients who are treated with bempedoic acid/FDC with ezetimibe prior to signed informed consent, initiation of bempedoic acid/FDC with ezetimibe must be within a maximum of three months prior to inclusion.
  • No contraindications exist according to the SmPC of bempedoic acid/FDC with ezetimibe.
  • No concurrent participation in an interventional study (simultaneous participation in other non-interventional study is possible)
  • Life expectancy \> 1 year.
  • No explicit exclusion criteria exist to avoid selection bias and to allow for documentation of routine clinical practice.

Exclusion

    Key Trial Info

    Start Date :

    January 30 2026

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    March 1 2029

    Estimated Enrollment :

    2560 Patients enrolled

    Trial Details

    Trial ID

    NCT07206472

    Start Date

    January 30 2026

    End Date

    March 1 2029

    Last Update

    December 24 2025

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.